Locus Biosciences
Locus Biosciences Raises $152M in Series C
Quick Facts
Locus Biosciences Raises $152M in Series C
Locus Biosciences has successfully raised $152M in a Series C at a $600M valuation led by Johnson & Johnson, Longitude Capital, Braeburn Capital, Domain Associates.
Company Overview
Locus Biosciences is a Biotech company headquartered in 9201 University City Boulevard, Charlotte, NC 28223, founded in 2015 with 150+ employees.
CRISPR-edited bacteriophages
Fundraising Details
- Amount Raised: $152M
- Round Type: Series C
- Valuation: $600M
- Date: 2024-02-16
- Investors: Johnson & Johnson, Longitude Capital, Braeburn Capital, Domain Associates
About Locus Biosciences
CRISPR-edited bacteriophages The company is positioned in the Biotech sector, serving a growing market with innovative solutions.
Key Information
- Headquarters: 9201 University City Boulevard, Charlotte, NC 28223
- Founded: 2015
- Team Size: 150+
- Industry: Biotech
What This Means
This funding round demonstrates strong investor confidence in Locus Biosciences's vision and execution. The capital will likely be used to:
- Scale Operations: Expand the team and operational capacity
- Product Development: Enhance existing products and develop new features
- Market Expansion: Enter new markets and strengthen presence in existing ones
- Technology Investment: Invest in infrastructure and technology capabilities
Industry Context
The Biotech sector continues to attract significant investment as companies innovate to meet evolving market demands. Locus Biosciences's successful fundraising reflects the strong fundamentals and growth potential in this space.
Valuation Milestone
Reaching a $600M valuation marks an important milestone for Locus Biosciences, positioning the company among notable players in the Biotech industry.
Looking Ahead
With this new capital, Locus Biosciences is well-positioned to execute on its growth strategy and continue building innovative solutions in the Biotech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.
This fundraising news was reported on 2024-02-16. For more information about Locus Biosciences, visit their headquarters at 9201 University City Boulevard, Charlotte, NC 28223.
About the Author
Related Company Reports
Anthropic Raises $2B in Series D
Anthropic, a AI/ML company based in San Francisco, CA, has raised $2B in Series D at a $18B valuation led by Menlo Ventures, Spark Capital, Google.
xAI Raises $6B in Series C
xAI, a AI/ML company based in San Francisco, CA, has raised $6B in Series C at a $40B valuation led by Sequoia Capital, a16z, Valor Equity.
Adept AI Raises $350M in Series B
Adept AI, a AI/ML company based in San Francisco, CA, has raised $350M in Series B at a $1B valuation led by General Catalyst, Spark Capital, Addition.